Turn Therapeutics (TTRX) Shares Outstanding (2024 - 2026)

Turn Therapeutics' Shares Outstanding (Entity) history runs 3 years deep, the most recent figure standing at $29.8 million for Q1 2026.

• On a quarterly basis, Shares Outstanding (Entity) rose 10.51% year-over-year to $29.8 million in Q1 2026; TTM through Mar 2026 was $29.8 million, a 10.51% increase from a year earlier, with the FY2025 full-year figure at $29.4 million, up 9.68% from the prior year.
• Shares Outstanding (Entity) grew to $29.8 million in Q1 2026 per TTRX's latest filing, from $29.4 million in the prior quarter.
• Across five years, Shares Outstanding (Entity) topped out at $29.8 million in Q1 2026 and bottomed at $26.6 million in Q3 2024.
• The 3-year median for Shares Outstanding (Entity) is $27.5 million (2025), against an average of $28.0 million.
• Across the five-year window, Shares Outstanding (Entity) increased 5.17% in 2025 and gained 10.51% in 2026, its largest moves.
• Year by year, Shares Outstanding (Entity) stood at $26.8 million in 2024, then rose by 9.68% to $29.4 million in 2025, then rose by 1.16% to $29.8 million in 2026.
• Per Business Quant, the three latest TTRX Shares Outstanding (Entity) figures stand at $29.8 million (Q1 2026), $29.4 million (Q4 2025), and $28.0 million (Q3 2025).